Indoco Remedies is planning an expansion programme at its sterile ophthalmic manufacturing facility in Goa with an investment of Rs. 1250 million. The company is also looking to set up a greenfield API facility at Patalganga in Maharashtra. It may be noted, the company had received the USFDA approval for the sterile ophthalmic facility for the third consecutive time. With this approval, all the three finished dosage and two API facilities are now USFDA approved.
Leave a Reply